Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsHow a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.
A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.
Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.
Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.
Symptomatic relief from nerve stimulation treatment may persist after stopping the treatment in most children with overactive bladder.
Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.
In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.
1.
Numerous Oncologists Are Concerned About the Cost of Genomic Testing.
2.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
3.
Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia
2.
The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies
3.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
4.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
5.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Efficient Management of First line ALK-rearranged NSCLC
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge